Refimprove date September 2008 Infobox Defunct Company company name Barr Pharmaceuticals Inc company logo Image Barr Pharmaceuticals Logo.png 200px company type foundation New York 1970 location Montvale, NJ , USA key people Bruce Downey, CEO industry Pharmaceuticals & Medical Devices products Generic and Proprietary Pharmaceuticals revenue Over 1 Billion USD fiscal year 2005 num employees 2000 homepage Barr Pharmaceuticals was a global specialty pharmaceutical company that operated in more than 30 countries worldwide. Barr were engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. History Barr Laboratories, Inc. was founded in 1970 by Edwin A. Cohen and was ultimately taken public under his leadership. On July 18, 2008, it was announced that rival firm, Teva Pharmaceutical Industries Ltd, would acquire Barr Pharmaceuticals Inc for 7.46 billion plus the assumption of net debt of approximately 1.5 billion. ref name Staff GEN2008 Citation last Staff date 2008 07 21 year 2008 issn 1937 8661 accessdate 2008 09 26 title Teva Coughs Up 7.46B for Barr Reinforcing Its Number One Spot in the Generics Market periodical Genetic Engineering & Biotechnology News series GEN News Highlights publisher Mary Ann Liebert url http www.genengnews.com news bnitem.aspx?name 38938670 ref Today Barr Laboratories exists only as a sub division of Teva Pharmaceuticals , as part of the Teva Active Pharmaceutical Ingredients TAPI division. Teva Pharmaceuticals develops and markets generic pharmaceuticals under various brand names, including the Barr Laboratories, Inc. label. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. References reflist Pharmaceutical companies of the United States Category Pharmaceutical companies of the United States de Barr Pharmaceuticals ... more details
Primary sources date March 2010 Aderis Pharmaceuticals was founded in 1994 to develop and commercialize pharmaceuticals and it is best known for the development of Rotigotine a dopamine agonist made for the treatment of Parkinson s disease . External links http www.aderis.com products rotigotine.htm Rotigotine SPM 962 The First Once a Day Transdermal Patch to Treat Parkinson s Disease http www.aderis.com index.asp Official site http www.aderis.com about index.htm About Aderis Pharmaceuticals Pharmaceutical companies of the United States Category Companies based in Middlesex County, Massachusetts Category Companies established in 1994 Category Pharmaceutical companies of the United States US company stub ... more details
linkrot date September 2011 ref improve date September 2011 IDUN Pharmaceuticals is a private biotechnology firm focused on developing drugs that target apoptosis mediated cell death in diseases related to cancer and inflammation. IDUN was founded by Larry Bock and Drs. Larry Fritz, John Reed and Robert Horvitz . http www.outsourcing pharma.com Preclinical Research Pfizer acquires Idun Pharmaceuticals IDUN was acquired by Pfizer in for 200 million. ref http www.outsourcing pharma.com Preclinical Research Pfizer acquires Idun Pharmaceuticals ref References Reflist Biotech stub Category Biotechnology companies ... more details
Infobox company company name Amylin Pharmaceuticals company logo Image Amylin Pharmaceuticals.svg 200px company type Public company Public NASDAQ AMLN company slogan Challenging Science, Changing Lives. foundation 1987 location San Diego, California , USA key people Daniel M. Bradbury ref name zenobank cite web url http www.zenobank.com index.php?symbol AMLN&page quotesearch title Company Profile for Amylin Pharmaceuticals Inc AMLN accessdate 2008 10 21 ref num employees 1,900 http finance.yahoo.com q pr?s amln industry Biotechnology revenue profit United States Dollar US 758M small FY 2009 small ref name 2009IncomeStatmenent wikinvest stock Amylin Pharmaceuticals AMLN Data Income Statement Amylin Pharmaceuticals AMLN annual SEC income statement filing via Wikinvest. ref operating income loss United States Dollar US 173M small FY 2009 small ref name 2009IncomeStatmenent net income loss United States Dollar US 186M small FY 2009 small ref name 2009IncomeStatmenent assets increase United States Dollar US 1.73B small FY 2009 small ref name 2009BalanceSheet wikinvest stock Amylin Pharmaceuticals AMLN Data Balance Sheet Amylin Pharmaceuticals AMLN annual SEC balance sheet filing via Wikinvest. ref equity increase United States Dollar US 423M small FY 2009 small ref name 2009BalanceSheet homepage http www.amylin.com www.amylin.com products Symlin pramlintide br Byetta exenatide Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA , that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes , obesity and other diseases. Currently, Amylin produces two drugs, Symlin pramlintide ... Drug Program. Amylin Pharmaceuticals. ref References Reflist External links Portal Companies Pharmaceutical ... Category Companies established in 1987 med company stub de Amylin Pharmaceuticals fr Amylin Pharmaceuticals it Amylin Pharmaceuticals ... more details
Infobox Company company name Verus Pharmaceuticals company logo Image Verus pharmaceuticals.png 175px Verus Pharmaceuticals Logo company type Privately held company Private company slogan foundation November 2002 November , 2002 location San Diego, California San Diego , California , United States key people Cam L. Garner, Chair official Chairman & Chief Executive Officer CEO br Robert W. Keith, President & Chief Operating Officer COO num employees industry Pharmaceutical company Pharmaceuticals products Twinject revenue operating income net income homepage http www.veruspharm.com www.veruspharm.com Verus Pharmaceuticals is a privately held pharmaceutical company based in San Diego, California. Founded in November 2002 by three former Dura Pharmaceuticals executives Bob Keith, Peter Schineller and Cam Garner, with an initial focus on the treatment of asthma , allergies , and related diseases and conditions, specifically in children. Verus is best known for it development and manufacturing of Twinject , the first and currently only two dose epinephrine autoinjector . The Twinject was latter licenced to Paladin Labs for manufacturing and distribution in Canada released in September, 2006. The licence for manufacturing and distribution in Europe and option for world wide distribution was sold to UCB. Verus Pharmaceuticals dissolved in March 2008 after selling its Twinjet product to Dey for 28 Million. See also List of companies headquartered in San Diego, California Pharmaceutical company Twinject References Coming Of Age Pediatric Pharmaceuticals Get Some Attention From Legislators And Venture Capitalists , http www.levinassociates.com publications hcfn hcfnheadlines 05 20hcfnhead 05hcfnhead06.htm Healthcare Corporate Finance News , June 2005 issue. http www.veruspharm.com www.veruspharm.com Verus Pharmaceuticals Official Site http www.twinject.com www.twinject.com Twinject Official Site Pharmaceutical companies of the United States Category Pharmaceutical companies of the United ... more details
Infobox Company company name DUSA Pharmaceuticals, Inc. company logo company type Public company Public NASDAQ http www.hoovers.com dusa pharmaceuticals ID 47973,ticker DUSA free co fin stockquote.xhtml DUSA foundation company slogan location Wilmington, Massachusetts , USA key people D. Geoffrey Shulman, MD, FRCP, Founder, Chairman, and CSO br Robert F. Doman, President and CEO industry Pharmaceuticals , br Healthcare products Levulan Levulan Kerastick , br BLU U , br ClindaReach , br Psoriatec , br METED Shampoo , br Nicomide revenue num employees homepage http www.dusapharma.com index.html http www.dusapharma.com DUSA Pharmaceuticals, Inc. NASDAQ DUSA is pharmaceutical company based in Wilmington, Massachusetts that specializes in dermatology products. The major focus of the company includes medications used in the treatment of actinic keratoses and acne vulgaris acne . In the first quarter of 2006 , DUSA Pharmaceuticals obtained Sirius Laboratories Inc. in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea. ref cite web url http findarticles.com p articles mi m0EIN is 2006 March 14 ai n26792987 title DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories date 2006 04 14 accessdate 2008 08 26 work BNET ref External links http www.lilly.com DUSA Pharmaceuticals, Inc. Official Web Site . References reflist 2 Category Wilmington, Massachusetts ... more details
unreferenced date September 2009 Respa Pharmaceuticals Inc is a pharmaceutical company founded in 1992. Its current headquarters is based in Addison, IL. Respa manufactures several pharmaceutical drugs, the most well known of which is the allergy drugs. Complete List of Products Vita Respa br External links http www.respainc.com main.html Respa Pharmaceuticals Pharmaceutical companies of the United States pharma stub US company stub Category Pharmaceutical companies of the United States Category Companies based in DuPage County, Illinois Category Addison, Illinois ... more details
Infobox Company company name King Pharmaceuticals company logo Image King Pharmaceuticals Logo.png company ... Annual Report.cfm King Pharmaceuticals 2009 Annual Report ref operating income 236 million United ... report homepage http www.kingpharm.com www.kingpharm.com King Pharmaceuticals NYSE KG , was the world ... 10 12 pfizer to buy king pharmaceuticals for 3 6 billion work The New York Times title Pfizer to Buy King Pharmaceuticals for 3.6 Billion date October 12, 2010 ref King produced a wide range of pharmaceutical ... , a muscle relaxant . King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee , Rochester ... owned subsidiaries were Monarch Pharmaceuticals, Inc. , King Pharmaceutical Research and Development, Inc., Meridian Medical Technologies Inc. , Parkdale Pharmaceuticals, Inc. , King Pharmaceuticals of Nevada, Inc., and Monarch Pharmaceuticals Ireland Limited. Company history King Pharmaceuticals ... company histories King Pharmaceuticals Inc Company History.html King Pharmaceuticals, Inc. Company ..., King obtained about twenty smaller branded drugs and then went public in June 1998. King Pharmaceuticals ... Roussel, Hoechst Celanese, its generic subsidiary Coply Pharmaceuticals and the agricultural Hoechst ... brands . Forbes. Zina Moukheiber. October 28, 2002. ref and King Pharmaceuticals President Jefferson .... ref name 136 print The King Pharmaceuticals wholly owned subsidiary Monarch Pharmaceuticals, Inc. another brother of John Gregory Joseph Gregory was then the president of Monarch Pharmaceuticals ... http www.custservices.com news.asp?up 8 Monarch Pharmaceuticals acquired . sanofi aventis Group ... of King Pharmaceuticals, Inc. to reintroduce the Hoechst branded prescription drug Altace back into the U.S. market under the King Pharmaceuticals,Inc. subsidiary Monarch Pharmaceuticals ... and Hoechst HMR. In late December 1998, King Pharmaceuticals d.b.a. Monarch Pharmaceuticals, Inc ... http archive.twst.com notes articles jab202.html King Pharmaceuticals CEO focuses on patented products ... more details
infobox company name Glenmark Pharmaceuticals logo File Glenmark Pharmaceuticals logo.svg 250px caption type Public traded as BSE 532296 br NSE GLENMARK genre fate predecessor successor foundation 1977 founder Gracias Saldanha defunct location city Mumbai , Maharashtra ref http www.glenmarkpharma.com UITemplate HtmlContainer.aspx?res P GLN CONTACT ref location country India location locations area served key people Glenn Saldanha, managing director MD & CEO ref cite web url http www.livemint.com 2009 07 01234216 If I were FM Glenn Saldanha.html title If I were FM & 124 Glenn Saldanha, managing director and CEO, Glenmark Pharmaceuticals Economy and Politics publisher livemint.com date 2009 07 01 accessdate 2010 09 30 ref industry Pharmaceuticals , Drugs & Healthcare products Medicines and Vaccines services revenue INRConvert 1031.10 c 2009 2010 ref cite web url http www.bseindia.com bseplus StockReach AdvanceStockReach.aspx?scripcode 532296 title BSE Plus publisher Bseindia.com date accessdate 2010 09 30 ref operating income net income aum assets equity owner num employees 7,000 ref cite web url http investing.businessweek.com research stocks snapshot snapshot.asp?ticker 2529483 title Glenmark Pharmaceuticals Ltd. 2529483 Stock Quote & Company Profile BusinessWeek publisher Investing.businessweek.com date accessdate 2010 09 30 ref parent divisions subsid Glenmark Generics Ltd ref cite web url http www.topnews.in companies glenmark pharmaceuticals title Glenmark Pharmaceuticals ... www.glenmarkpharma.com footnotes intl yes Glenmark Pharmaceuticals BSE 532296 NSE GLENMARK is one ... download glenmark pharma 23oct.pdf title about Glenmark Pharmaceuticals publisher www.ibef.org ... subsidiaries, Glenmark Pharmaceuticals USA, Glenmark Pharmaceuticals UK. Glenmark Pharmaceuticals SA. ref cite web url http www.domain b.com companies companies g glenmark pharmaceuticals 20051226 acquires.htm title Glenmark Pharmaceuticals acquires Bouwer Bartlett, South Africa publisher domain b.com ... more details
Unreferenced date November 2010 Ovation Pharmaceuticals , founded in 2000 by Jeffrey Aronin and Dr. Joel E. Bernstein, is a manufacturer of pharmaceutical s products including the popular selling ADHD medicine Desoxyn , brand name for methamphetamine hydrochloride, and Vigabatrin which is an anticonvulsant that inhibits the catabolism of GABA and is indicated for epilepsy and substance abuse. Ovation is a privately held corporation based on a business model of acquiring mature but under promoted pharmaceuticals, as well as pharmaceutical candidates which are far along the development and Food and drug administration FDA certification processes. The headquarters of Ovation Pharma is located in Deerfield, Illinois . A major office is also located near Lebanon, New Jersey . On February 9, 2009, it was announced http epn.dk brancher medicin article1597387.ece , that Ovation was bought by Lundbeck . External links http www.ovationpharma.com Ovation Pharmaceuticals Web site Pharmaceutical companies of the United States Category Pharmaceutical companies of the United States Category Companies based in Deerfield, Illinois med company stub ... more details
Infobox Company company name Endo Pharmaceuticals company logo Image Endo Pharmaceuticals Logo.png company type Public company Public Nasdaq ENDP company slogan foundation location Chadds Ford, Pennsylvania num employees industry Pharmaceutical products revenue net income homepage http www.endo.com www.endo.com Endo Pharmaceuticals Inc. is an American pharmaceutical company. It was created as a result of a management buyout from DuPont Merck in 1997. Three DuPont Merck executives Carol A. Ammon, Chairman, President & CEO, and Mariann T. MacDonald, Executive Vice President, Operations, along with another colleague purchased all of Endo Laboratories L.L.C. s generic products along with 12 important brand products, including Percocet and Percodan . The new company was called Endo Pharmaceuticals Inc. Endo acquired Algos Pharmaceutical Corporation through a merger in July 2000 and began to trade publicly NASDAQ ENDP . Endo Pharmaceuticals successfully completed a secondary offering for a total ... of prescription pharmaceuticals used primarily to treat and manage pain. Endo rents some ... of the Excedrin distributed across the entire nation. In 2009, Endo bought Indevus Pharmaceuticals ... articles 2009 01 06 endo to buy indevus pharmaceuticals title Endo to buy Indevus author Associated ... business healthcare articles 2009 01 06 endo to buy indevus pharmaceuticals title Endo to buy ... news author Staff title Endo Pharmaceuticals url http www.delawareonline.com apps pbcs.dll article ... publisher Endo Pharmaceuticals ref The agreement of 6 January 2006 for Endo Pharmaceuticals to market ... with the Synera patch. Zars Pharmaceuticals is the patent holder for Synera. ref http www.wikinvest.com stock Endo Pharmaceuticals Holdings 28ENDP 29 Zars 20Pharma ref The rights to Synera passed to Nuvo Research of Canada in May, 2011 upon the acquisition of ZARS Pharmaceuticals by Nuvo ... Pharmaceuticals Refend External links official http www.endo.com Pharmaceutical companies of the United ... more details
Titan Pharmaceuticals, Inc. is a California biopharmaceutical company. Titan develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease , bone disease , and other disorders primarily in the United States . Its products in development include probuphine , in Phase III clinical trials for the treatment of opioid dependence iloperidone , has been approved by FDA for the treatment of schizophrenia and related psychotic disorders and spheramine , in Phase IIb for the treatment of advanced Parkinson s disease . The company s potential products also include DITPA, in Phase II for the treatment of congestive heart failure and hyperlipidemia. Titan has a strategic alliance with Schering AG for the development of spheramine and Vanda Pharmaceuticals, Inc. for the development of iloperidone. Titan Pharmaceuticals was founded by Louis R. Bucalo. ref http www.bizjournals.com gen executive.html?excode 7814DDD61306493D959AD45A75DA26D9 Louis R. Bucalo ref The company was incorporated in 1992 and is based in South San Francisco , California. References Reflist External links http titanpharm.com Titan Pharmaceuticals website Pharmaceutical companies of the United States Category Pharmaceutical companies of the United States Category Companies based in San Mateo County, California US company stub ... more details
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 ref http www.reliantrx.com investor press releases 121907.pdf Reliant Redirect GlaxoSmithKline Bot generated title ref . It was known for six major products, including InnoPran XL , a propranolol based beta blocker . References references Category Pharmaceutical companies med company stub ... more details
unreferenced date April 2010 Infobox Company company name Torrent Pharmaceuticals Limited company type Public Bombay Stock Exchange BSE http www.bseindia.com price finder stockreach.asp?scripcd 500420 TORRENTPH company logo Image Torrent Pharma Logo.gif Torrent Pharmaceuticals logo 120px company slogan not just healthcare lifecare foundation 1959 location Ahmedabad , India key people Sudhir Mehta, Chairman num employees 4000 2006 industry Pharmaceuticals products revenue profit Rupee INR 16.16 billion Mar 2009 net income profit Rupee INR 1.84 billion Mar 2009 homepage http www.torrentpharma.com www.torrentpharma.com Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group . Based in Ahmedabad , it was promoted by U. N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally. br Moreover, it has 7 fully owned subsidiares Heumann Pharma GmbH & Co Generica KG, Germany Torrent Pharma GmbH, Germany Torrent do Brasil Ltda., Brazil ZAO Torrent Pharma, Russia Torrent Pharma Inc., United States Torrent Pharma Philippines Inc., Philippines Torrent Pharma Canada Inc., Canada Torrent Pharmaceuticals acquired Heumann GmbH, a Pfizer group company in 2005. Operations The company s key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs. Its operations locations are Manufacturing plant at Chhatral, Near Kadi, in North of Gujarat Manufacturing plant at Baddi, Himachal Pradesh Manufacturing plant at Sikkim Manufacturing plant at Dahej, Gujarat under progress Research Centre, Ahmedabad Gandhinagar region, Gujarat Corporate Office, off Ashram Road, Ahmedabad External links http www.torrentpharma.com Home page of Torrent Pharmaceuticals Limited Torrent Group milestones http www.torrentlimited.com milestones pharma.htm Torrent Pharma media reports http www.torrentpharma.com news ... more details
Panacos Pharmaceuticals is a Delaware based pharmaceutical corporation founded in 1999. Panacos is engaged in the discovery and development of inventive therapeutics and technologies to help fight major viral illnesses. As of now, their focus is on Human Immunodeficiency Virus HIV anti infectives, such as Bevirimat . Bevirimat is currently their only drug in clinical trials , the rest are in preclinical trials or only in the research phase of development. Panacos merged with V.I. Technologies, another Delaware based company, on March 11, 2005. External links http www.panacos.com Panacos Pharmaceuticals Main Website Pharmaceutical companies of the United States Category Pharmaceutical companies of the United States med company stub ... more details
Infobox Company company name Arena Pharmaceuticals company logo Image Arena pharmaceuticals logo.PNG 220px Arena Pharmaceuticals company type Public company Public NASDAQ ARNA company slogan foundation location San Diego, California , USA key people Jack Lief, cofounder and CEO br Dominic Behan, co founder and senior scientist num employees industry Biotechnology revenue profit United States Dollar US 10.4M small FY 2009 small ref name 2009IncomeStatmenent wikinvest stock Arena Pharmaceuticals ARNA Data Income Statement Arena Pharmaceuticals ARNA annual SEC income statement filing via Wikinvest. ref operating income loss United States Dollar US 138M small FY 2009 small ref name 2009IncomeStatmenent net income loss United States Dollar US 153M small FY 2009 small ref name 2009IncomeStatmenent assets decrease United States Dollar US 236M small FY 2009 small ref name 2009BalanceSheet wikinvest stock Arena Pharmaceuticals ARNA Data Balance Sheet Arena Pharmaceuticals ARNA annual SEC balance sheet filing via Wikinvest. ref equity decrease United States Dollar US 74.6M small FY 2009 small ref name 2009BalanceSheet market cap homepage http www.arenapharm.com www.arenapharm.com products in development Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California . The company is developing oral medications that target G protein coupled receptor s. Currently none of the drugs is approved by the U.S. Food and Drug Administration , but several are in Phase I to III testing, namely stand January 2009 Lorcaserin , Phase III , indication obesity . APD791 , Phase I, indication arterial thrombosis . APD916 , entering Phase I, indication pulmonary hypertension . Niacin receptor antagonist, Phase I, indication arteriosclerosis , in conjunction with Merck & Co. Merck APD597 , Phase II, indication diabetes type 2 , in conjunction with Ortho McNeil Janssen See also List of biotechnology companies References references External links http www.arenapharm.com wt ... more details
Image Ferring St Prex.jpg thumb right 200px Ferring Pharmaceuticals, Global Headquarters in St Prex , Switzerland Ferring Pharmaceuticals is a pharmaceutical company that specializes in the development and marketing of drugs for use in human medicine . It was founded by Frederik Paulsen Sr in Malm , Sweden , in 1950, initially as the Nordiska Hormon Laboratoriet , renamed Ferring in 1954. A ferring in North Frisian Frisian is a person from the island F hr off the western coast of Germany. Mr. Paulsen s family originates from that island. The first major breakthrough was the synthetic production of oxytocin and vasopressin in 1961. With further growth and expansion, the headquarters moved to Copenhagen , Denmark , and subsequently to Switzerland . In August 2011, the company held over 4,000 employees with manufacturing facilities in Europe , South America , Israel and China . Products are used in gastroenterology , urology , reproductive health and endocrinology . In 2007 Alexandra, Countess of Frederiksborg joined the Danish board of directors of Ferring Pharmaceuticals. ref http msndk.starlounge.com article.cfm?objectid 11057 Countess Alexandra gets a million dollar job Grevinde Alexandra f r millionjob , MSN Gossip, 26. september 2007 ref ref http www.dr.dk Nyheder Penge 2007 09 26 072634.htm Alexandra in the board of directors of Ferring Alexandra i Ferrings bestyrelse , DR Nyheder, 26. september 2007 ref References references External links http www.ferring.com Ferring Global Website Category Pharmaceutical companies of Switzerland Category Pharmaceutical companies of Sweden Category Biotechnology companies Category Multinational companies da Ferring Pharmaceuticals de Ferring fr Ferring Pharmaceuticals no Ferring Pharmaceuticals sv Ferring ... more details
Infobox Company company name Bradley Pharmaceuticals, Inc. company logo Image BradPharmLogo.jpeg 340px center company type Merged foundation 1985 closed February 21, 2008 location Fairfield Township, Essex County, New Jersey key people Daniel Glassman Chief Executive Officer CEO industry Pharmaceutical company Pharmaceuticals products Adoxa , Zoderm , Pamine Forte , Kerol revenue US 145 million 2006 num employees 300 as of December 31, 2006 successor Nycomed homepage www.bradpharm.com Bradley Pharmaceuticals was a pharmaceutical company headquartered in Fairfield Township, Essex County, New Jersey . The company was founded in 1985 by Daniel Glassman who was also its CEO. The company marketed to niche physician specialties in the U.S. and 38 international markets. Bradley Pharmaceuticals comprised Doak Dermatologics, specialized in therapies for dermatology and podiatry Kenwood Therapeutics, providing gastroenterology, OB GYN and other internal medicine brands and A. Aarons, which markets authorized generic versions of Doak and Kenwood therapies. Doak Dermatologics Doak Dermatologics was the division of Bradley Pharmaceuticals that marketed products to dermatologists. Its flag products were Zoderm which is a topical anti acne product. Adoxa doxycycline was an antibiotic intended to treat mild to severe acne. Kenwood Therapeutics Kenwood was the affiliate brand that worked with therapeutic products. Among the most prescribed ones were Entsol which is a respiratory therapeutic product and Pamine which is intended to treat digestive problems. Public trading The company was publicly traded at the NYSE by its code BDY since May 2003. Nycomed Merger Bradley Pharmaceuticals merger merged with Nycomed , a European company. The merger was completed on February 21, 2008, and Bradley became an integral part of Nycomed. ref http www.altanainc.com News Bradley 071030 PR.pdf ref References reflist Pharmaceutical companies of the United States Category Companies based in Essex County ... more details
Infobox Company company name Anthera Pharmaceuticals, Inc. company logo Image Anthera Pharmaceuticals logo.jpg company type Public company Public traded as nasdaq ANTH foundation 2004 location Hayward, California Hayward , California , United States U.S. key people Paul F. Truex small br President and Chief Executive Officer CEO small br industry Pharmaceuticals homepage http www.anthera.com Anthera.com Anthera Pharmaceuticals, Inc. nasdaq ANTH is a pharmaceutical company that specializes in developing treatments for serious cardiovascular disease cardiovascular and autoimmune diseases . It is headquartered in Hayward, California . ref name 10k cite web url http www.sec.gov Archives edgar data 1316175 000095012311022379 f58478e10vk.htm title Form 10 K, Anthera Pharmaceuticals, Inc. date March 7, 2011 publisher U.S. Securities and Exchange Commission ref Product Candidates Anthera has one drug in Clinical trial Phase III Phase III of clinical development, and two in Clinical trial Phase II Phase II . ref name 10k ref name products cite web url http www.anthera.com products overview.asp title Product Cantidates Overview accessdate August 4, 2011 publisher Anthera Pharmaceuticals, Inc. ref Varespladib methyl , an investigational anti inflammatory agent for the treatment of acute coronary syndrome . Blisibimod , an investigational B cell activating factor anti BAFF molecule for the treatment of systemic lupus erythematosus . Varespladib Intravenous varespladib Varespladib sodium , an investigational anti inflammatory agent for the treatment of acute chest syndrome . References reflist External Links Portal box California Companies http www.anthera.com Official website Pharmaceutical companies of the United States Category Pharmaceutical companies of the United States Category Companies in the NASDAQ Biotechnology Index ... more details
POV date May 2008 Infobox company company name Vertex Pharmaceuticals Incorporated company logo Image VertexPharma logo.png 220px Vertex Pharmaceuticals company type Corporation NASDAQ http quotes.nasdaq.com asp SummaryQuote.asp?symbol VRTX VRTX foundation 1989 location Cambridge, Massachusetts key people Matthew Emmens , President, CEO John J. Alam, M.D. , Executive Vice President, Medicines Development and Chief Medical Officer industry Pharmaceuticals Biopharmaceuticals & Biotherapeutics http www.hoovers.com free search simple xmillion vertex pharmaceuticals ID 15321 free co factsheet.xhtml products http www.vpharm.com current projects.html Product Pipeline revenue profit 250 million United States dollar USD 2006 homepage http www.vrtx.com www.vrtx.com Vertex Pharmaceuticals is a biotechnology company with activities spanning the length of the pharmaceutical product pipeline, from target identification through to clinical trials and marketing. Most of its activity has been in collaboration with much larger pharmaceutical firms, though some of its recent work has been done independently. Vertex was founded in 1989 by Kevin Kinsella and Larry Bock of Avalon Ventures and Gary Aronson. Kevin, Larry and Gary recruited Joshua Boger from Merck Pharmaceuticals. Joshua Boger retired in 2009. ref name Globe Rearranging the Corporate DNA, Boston Sunday Globe , April 24, 2011. page G1 ref Vertex was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Vertex went about understanding a disease and then tried to develop ... 2010, Vertex Pharmaceuticals completed its first New Drug Application NDA under its own name for the drug ... Pharmaceuticals Incorporated homesite work 2004 Annual Report url http www.vrtx.com accessdate 18 May 2004 cite web title Vertex Pharmaceuticals Incorporated press release url http investors.vrtx.com ... med company stub fr Vertex Pharmaceuticals ... more details
Infobox company company name OSI Pharmaceuticals, Inc. company logo File OSI Pharmaceuticals logo .png 200px company type Subsidiary slogan Shaping Medicine, Changing Lives ref name OSIWhoWeAre foundation 1983 location Melville, New York key people Colin Goddard, CEO br Michael G. Atieh, CFO br Robert A. Ingram, Chairman ref name Hoover s num employees 554 2007 02 ref name NumEmp cite web url http media.corporate ir.net media files irol 70 70584 reports ar2006.pdf title 2006 Annual Report accessdate 2008 01 20 date 2007 02 28 format PDF publisher OSI Pharmaceuticals pages pg22 quote As of February 7, 2007, our number of employees decreased to 554, of which 276 primarily are involved in research, development and manufacturing activities and 140 primarily are involved in the commercialization of our products. ref industry Biopharmaceuticals & Biotherapeutics ref name Hoover s products Medical Laboratories & Research revenue increase 375.7 Million United States dollar USD 2006 ref name Hoover s2 cite web url http www.hoovers.com osi pharmaceuticals ID 14327,ticker free co fin factsheet.xhtml title OSI Pharmaceuticals Financials accessdate 2008 01 20 work Hoover s publisher EDGAROnline ... present homepage http www.osip.com www.osip.com OSI Pharmaceuticals , Inc. is an American pharmaceutical ... 01 20 date 2008 01 17 quote OSI Pharmaceuticals Inc OSIP ref Though oncology is the top priority ... Who We Are accessdate 2008 01 20 publisher OSI Pharmaceuticals ref ref name Hoover s cite web url http www.hoovers.com global cobrands nasdaq factsheet.xhtml?ID 14327 title OSI Pharmaceuticals, Inc ... PDF publisher OSI Pharmaceuticals pages pg5 quote As a result of our decision to divest the eye disease ... title Products & Pipeline accessdate 2008 01 20 publisher OSI Pharmaceuticals ref ref name GENENG200706 ... with Genentech. References Reflist 2 External links http www.osip.com OSI Pharmaceuticals Portal Companies Pharmaceutical companies of the United States DEFAULTSORT Osi Pharmaceuticals Category ... more details
Cortex Pharmaceuticals OTCBB CORX is a pharmaceutical company based in Irvine, California specializing in positive allosteric modulators of the AMPA receptor known as Ampakines . History February 2005 Cortex received U.S. Food and Drug Administration approval to begin Phase II clinical trials for CX717 for use as a treatment for Alzheimer s, ADHD and Sleep disorders. ref http www.ocregister.com ocr sections business business article 394530.php News Today s Orange County business briefs OCRegister.com Bot generated title ref br 2006 The FDA halted clinical trials for CX717 because they feared the drug was toxic. They later allowed testing to continue but at doses too low to have any effect. ref http www.ocregister.com ocregister money article 1594082.php Money Innovative biomed companies woo investors OCRegister.com Bot generated title ref br July 2007 The FDA gave Cortex permission to continue with clinical trials for CX717, as a treatment for Alzheimer s disease . br September 2007 Cortex filed with the FDA to test CX717 as a treatment for ADHD . br October 2007 Dr. Pierre Tran became Chief Medical Officer at Cortex after the FDA refused to let the company proceed with Phase II clinical trials for CX717 as a treatment for ADHD. ref http ocbiz.freedomblogging.com category biomedical cortex pharmaceuticals Cortex Pharmaceuticals OC Business News OCRegister.com Bot generated title ref br March 2008 German regulators approved clinical studies for using CX717 to prevent breathing problems caused by opiate pain killers. May 2008 President and CEO Dr. Roger Stoll announced that he was resigning and would be replaced by Mark Varney. ref http innovation.freedomblogging.com category innovation within companies cortex pharmaceuticals Cortex Pharmaceuticals Biomedical Innovation with Colin Stewart OCRegister.com Bot generated title ref References reflist External links http cortexpharm.com Cortex s official website http investorshub.advfn.com boards board.aspx?board id 3252 Cortex ... more details
Unreferenced date June 2010 Notability date June 2010 Infobox company company name Laborat rios Crist lia S.A. company logo company type Privately held company Private foundation 1972 location Itapira , Brazil key people Ogari Pacheco, CEO area served industry Pharmaceuticals & Healthcare products Drug br Generic drug revenue profit United States dollar US 360.0 Million 2010 operating income net income num employees slogan parent subsid homepage http www.cristalia.com.br www.cristalia.com.br Crist lia is a Brazilian pharmaceutical company founded in 1972 and based in Itapira , State of S o Paulo . Its focused in psychiatric and expertise in areas such as anesthesia and allergology. Today the company covers the entire national territory and export its products reaches about 40 countries from Latin America , Middle East , Africa , Asia and United States . Crist lia maintains cooperative agreements with several pharmaceutical companis around the world. Together with Grupo EMS Sigma Pharma EMS , Ach pharmaceuticals Ach , Neo Qu mica and Eurofarma , Crist lia is part of the team s most important Brazilian pharmaceuticals. References Category Companies based in S o Paulo Category Pharmaceutical companies of Brazil pt Crist lia laborat rio ... more details
Image Norwich Pharmaceuticals Logo.jpg right thumb 200px Logo Norwich Pharmaceuticals is a manufacturer, packager and distributor of prescription drugs and over the counter products. Laboratory support services include stability evaluation, microbiological testing, analytical testing and method development. The company was formed in 1887. ref Norwich Pharmaceuticals Company Overview, http www.norwichpharma.com overview overview.htm ref ref Norwich Pharmaceuticals History, http www.norwichpharma.com overview history.htm ref ref Cholera Infantum Definition, http www.sedgleymanor.com diseases diseases a e.html ref ref Pepto Bismol, http www.pepto bismol.com faqs.shtml ref ref History of Pepto Bismol, http www.pepto bismol.com history.shtml ref ref The Norwich Pharmacal Company Antique Stock and Bond Certificates, http www.stocklobster.com 2348.html ref History The Norwich Pharmaceutical Company was established in Norwich city , New York Norwich, New York in 1887. In 1893, Norwich introduced Unguentine to the medical profession as the first antiseptic surgical dressing. The company s mixture called Cholera Infantum , later renamed Pepto Bismol , appeared for the first time in 1901. Its principal use was for infants with severe diarrhea. In 1907, Acetylsalicylic acid aspirin tablets were added to the company s product line. In 1939, Norwich Pharmaceutical stock was listed on the New York Stock Exchange . During World War II , the company earned the Army Navy E Award with four added stars in recognition of its support of the troops and war effort. In 1982, the company, then called Norwich Eaton Pharmaceuticals, became a wholly owned subsidiary of the Procter & Gamble Company. In the mid 1990s, Norwich constructed an Intermediate Potency solid dose form facility, from which the osteoporosis drug Actonel was launched. The Norwich, NY, plant was purchased from Procter & Gamble Pharmaceuticals in 2001 and transitioned into its current role as an outsourcing provider to the pharmaceutical ... more details
Infobox company company name Valeant Pharmaceuticals International company logo File Valeant logo.svg 248px Valeant Pharmaceuticals International company type Public company traded as NYSE VRX br TSX VRX foundation 1960 location Mississauga , Ontario , Canada key people J. Michael Pearson small Chairman & CEO small industry Pharmaceutical industry products Cesamet nabilone br Efudex br Mestinon br Diastat br Ribavirin licensed to Schering Plough Schering Plough revenue 683 million 2004 homepage http www.valeant.com www.valeant.com Valeant Pharmaceuticals International, Inc. NYSE VRX , TSX VRX is a pharmaceutical company with activities spanning the Drug discovery drug discovery pipeline from target identification through clinical trial s and commercialization . The focus of the company is on neurology , dermatology and infectious disease with several drugs in late stage clinical trials and several currently on the market. In addition, Valeant has a portfolio of more than 500 products from its prior history as a group of speciality chemical and radiochemical research, development and supply companies with a history stretching back to the 1960s. Kinerase R , used kinetin as active entity is one of the most famous product of this company. History The company has undergone major management, operational and strategic restructurings since the 1990s when shareholders of several group units approved the merger of ICN Pharmaceuticals founded by Milan Pani , ICN Biomedicals, SPI Pharmaceuticals and Viratek into a new global entity, ICN Pharmaceuticals, the immediate forebear of Valeant. In 2010 Biovail Corporation merged with Valeant Pharmaceuticals International. ref cite news url http www.forbes.com feeds ap 2008 10 09 ap5530646.html deadurl yes Dead link date September 2011 bot RjwilmsiBot ref On May 2011, former Biovall Corporation Chairman and CEO Eugene Melnyk was banned ... 2010, Valeant announced that they are acquiring Aton Pharmaceuticals for about 318 million. ref cite ... more details
Encyclopedia
top
